Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Prev Chronic Dis. 2020 Jul 23;17:E68. doi: 10.5888/pcd17.200068.
The Community Outreach and Patient Empowerment (COPE) intervention provides integrated outreach through community health representatives (CHRs) to people living with diabetes in Navajo Nation. The aim of this study was to identify groups for whom the intervention had the greatest effect on glycated hemoglobin A (HbA).
We analyzed de-identified data extracted from routine health records dated from December 1, 2010, through August 31, 2014, to compare net change in HbA among COPE patients and non-COPE patients. We used linear mixed models to assess whether the intervention was modified by age, sex, preferred language, having a primary care provider, baseline HbA, or having a mental health condition.
Age, having a primary care provider, and baseline HbA significantly modified HbA levels. Among patients aged 64 or younger, COPE participation was associated with a net decrease in HbA of 0.77%; among patients aged 65 or older, the net decrease was 0.49% (P = .03). COPE participation was associated with a steeper decrease in HbA among patients without a primary care physician (net decrease, 0.99%) than among patients with a primary care provider (net decrease, 0.57%) (P = .03). COPE patients with a baseline HbA >9% had a net decrease of 0.70%, while those with a baseline HbA ≤9% had a net decrease of 0.34% (P = .01). We found no significant differences based on sex, preferred language, or having a mental health condition.
Findings suggest that the COPE intervention was robust and equitable, benefiting all groups living with diabetes in Navajo Nation, but conferring the greatest benefit on the most vulnerable.
社区外展和患者赋权(COPE)干预措施通过社区卫生代表(CHR)为纳瓦霍族的糖尿病患者提供综合外展服务。本研究旨在确定对糖化血红蛋白 A(HbA)影响最大的干预对象群体。
我们分析了从 2010 年 12 月 1 日至 2014 年 8 月 31 日提取的常规健康记录中的匿名数据,以比较 COPE 患者和非 COPE 患者的 HbA 净变化。我们使用线性混合模型来评估干预措施是否受年龄、性别、首选语言、是否有初级保健提供者、基线 HbA 或是否存在心理健康状况的影响。
年龄、有初级保健提供者和基线 HbA 显著改变了 HbA 水平。在 64 岁或以下的患者中,COPE 参与与 HbA 净降低 0.77%相关;在 65 岁或以上的患者中,净降低为 0.49%(P=0.03)。与有初级保健医生的患者相比(净降低 0.57%),没有初级保健医生的患者中 COPE 参与与 HbA 的下降更为陡峭(净降低 0.99%)(P=0.03)。COPE 患者的基线 HbA>9%有 0.70%的净降低,而基线 HbA≤9%的患者有 0.34%的净降低(P=0.01)。我们没有发现基于性别、首选语言或是否存在心理健康状况的显著差异。
研究结果表明,COPE 干预措施是强大且公平的,有益于纳瓦霍族的所有糖尿病患者群体,但对最脆弱的群体带来最大的益处。